Login / Register Current Flag
Trading advice
Trading advice

GlobalData

Syphilis Diagnostic Tests – Medical Devices Pipeline Assessment, 2016 $2500

Syphilis Diagnostic Tests – Medical Devices Pipeline Assessment, 2016 Summary GlobalData’s Medical Devices sector report, “Syphilis Diagnostic Tests – Medical Devices Pipeline Assessment, 2016″ provides an overview of Syphilis Diagnostic ...Read the full article

1st July, 2016 • GlobalData

 

Herpes Simplex Virus (HSV) Diagnostic Tests – Medical Devices Pipeline Assessment, 2016 $2500

Herpes Simplex Virus (HSV) Diagnostic Tests – Medical Devices Pipeline Assessment, 2016 Summary GlobalData’s Medical Devices sector report, “Herpes Simplex Virus (HSV) Diagnostic Tests – Medical Devices Pipeline Assessment, 2016″ ...Read the full article

1st July, 2016 • GlobalData

 

Ophthalmic Viscoelastic Devices (OVD) – Medical Devices Pipeline Assessment, 2016 $2500

 Ophthalmic Viscoelastic Devices (OVD) – Medical Devices Pipeline Assessment, 2016 Summary GlobalData’s Medical Devices sector report, “Ophthalmic Viscoelastic Devices (OVD) – Medical Devices Pipeline Assessment, 2016″ provides an overview of ...Read the full article

6th June, 2016 • GlobalData

 

Respiratory Assist Devices – Medical Devices Pipeline Assessment, 2016 $2500

 Respiratory Assist Devices – Medical Devices Pipeline Assessment, 2016 Summary GlobalData’s Medical Devices sector report, “Respiratory Assist Devices – Medical Devices Pipeline Assessment, 2016″ provides an overview of Respiratory Assist ...Read the full article

6th June, 2016 • GlobalData

 

Endotracheal Tubes – Medical Devices Pipeline Assessment, 2016 $2500

 Endotracheal Tubes – Medical Devices Pipeline Assessment, 2016 Summary GlobalData’s Medical Devices sector report, “Endotracheal Tubes – Medical Devices Pipeline Assessment, 2016″ provides an overview of Endotracheal Tubes currently in ...Read the full article

6th June, 2016 • GlobalData

 

Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Medical Devices Pipeline Assessment, 2016 $2500

 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Medical Devices Pipeline Assessment, 2016 Summary GlobalData’s Medical Devices sector report, “Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Medical Devices Pipeline ...Read the full article

6th June, 2016 • GlobalData

 

Global Oil and Gas Pipelines Industry Outlook to 2020 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Pipelines $8000

Global Oil and Gas Pipelines Industry Outlook to 2020 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Pipelines Summary “Global Oil and Gas Pipelines Industry ...Read the full article

2nd June, 2016 • GlobalData

 

Global Planned Oil and Gas Pipelines Industry Outlook to 2020 – Capacity and Capital Expenditure Forecasts with Details of All Planned Pipelines $5000

Global Planned Oil and Gas Pipelines Industry Outlook to 2020 – Capacity and Capital Expenditure Forecasts with Details of All Planned Pipelines Summary “Global Planned Oil and Gas Pipelines Industry ...Read the full article

2nd June, 2016 • GlobalData

 

Geothermal Power in Russian Federation, Market Outlook to 2030, Update 2016 – Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles $2500

Geothermal Power in Russian Federation, Market Outlook to 2030, Update 2016 – Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary “Geothermal Power in Russian ...Read the full article

1st June, 2016 • GlobalData

 

Production and Capital Expenditure Outlook for Key Planned Upstream Projects for Canadian Oil Sands $1500

Production and Capital Expenditure Outlook for Key Planned Upstream Projects for Canadian Oil Sands Summary In Canada, most of the planned oil sands projects will be the expansion phases of ...Read the full article

1st June, 2016 • GlobalData

 

Global Capacity and Capital Expenditure Outlook for Oil Storage – Project Changes and Cancellations Cut Projected Storage Capacity 10% by 2019 $1500

Global Capacity and Capital Expenditure Outlook for Oil Storage – Project Changes and Cancellations Cut Projected Storage Capacity 10% by 2019 Summary Asia will drive the growth in the global ...Read the full article

1st June, 2016 • GlobalData

 

Mexico Power Market Outlook to 2030, Update 2016 – Market Trends, Regulations, and Competitive Landscape $2500

Mexico Power Market Outlook to 2030, Update 2016 – Market Trends, Regulations, and Competitive Landscape Summary This report elaborates Mexico’s power market structure and provides historical and forecast numbers for ...Read the full article

1st June, 2016 • GlobalData

 

Partnerships, Licensing, Investments and M&A Deals and Trends for April 2016 in Pharmaceuticals $1000

Partnerships, Licensing, Investments and M&A Deals and Trends for April 2016 in Pharmaceuticals Summary GlobalData’s “Partnerships, Licensing, Investments and M&A Deals and Trends for April 2016 in Pharmaceuticals” report is ...Read the full article

1st June, 2016 • GlobalData

 

Argentina Power Market Outlook to 2030, Update 2016 – Market Trends, Regulations, and Competitive Landscape $2500

 Argentina Power Market Outlook to 2030, Update 2016 – Market Trends, Regulations, and Competitive Landscape Summary This report elaborates Argentina’s power market structure and provides historical and forecast numbers for ...Read the full article

1st June, 2016 • GlobalData

 

Medical Equipment Annual Deals Analysis: M&A and Investments Trends – 2015 $3500

Medical Equipment Annual Deals Analysis: M&A and Investments Trends – 2015 Summary “GlobalData’s “Medical Equipment Annual Deals Analysis: M&A and Investments Trends – 2015” report is an essential source of ...Read the full article

1st June, 2016 • GlobalData

 

Renewable Power Market, Policy Changes, April 2016 $500

Renewable Power Market, Policy Changes, April 2016 Summary April 2016 saw a number of policy changes in the global renewable power market. In North America, in the US, the Maryland ...Read the full article

1st June, 2016 • GlobalData

 

Hydropower in Russian Federation, Market Outlook to 2030, Update 2016 – Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles $2500

Hydropower in Russian Federation, Market Outlook to 2030, Update 2016 – Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary “Hydropower in Russian Federation, Market ...Read the full article

1st June, 2016 • GlobalData

 

Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016 $2500

Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData’s clinical trial report, “Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016″ provides an overview of Hodgkin Lymphoma clinical trials scenario. ...Read the full article

31st May, 2016 • GlobalData

 

Emphysema Global Clinical Trials Review, H1, 2016 $2500

Emphysema Global Clinical Trials Review, H1, 2016 Summary GlobalData’s clinical trial report, “Emphysema Global Clinical Trials Review, H1, 2016″ provides an overview of Emphysema clinical trials scenario. This report provides ...Read the full article

31st May, 2016 • GlobalData

 

Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016 $2500

Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016 Summary GlobalData’s clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016″ provides an overview of Hepatocellular Carcinoma clinical trials scenario. ...Read the full article

31st May, 2016 • GlobalData

 

Pancreatic Cancer Global Clinical Trials Review, H1, 2016 $2500

Pancreatic Cancer Global Clinical Trials Review, H1, 2016 Summary GlobalData’s clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H1, 2016″ provides an overview of Pancreatic Cancer clinical trials scenario. ...Read the full article

31st May, 2016 • GlobalData

 

Diabetic Macular Edema Global Clinical Trials Review, H1, 2016 $2500

Diabetic Macular Edema Global Clinical Trials Review, H1, 2016 Summary GlobalData’s clinical trial report, “Diabetic Macular Edema Global Clinical Trials Review, H1, 2016″ provides an overview of Diabetic Macular Edema ...Read the full article

31st May, 2016 • GlobalData

 

Indolent Lymphoma Global Clinical Trials Review, H1, 2016 $2500

Indolent Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData’s clinical trial report, “Indolent Lymphoma Global Clinical Trials Review, H1, 2016″ provides an overview of Indolent Lymphoma clinical trials scenario. ...Read the full article

31st May, 2016 • GlobalData

 

Rhabdomyosarcoma Global Clinical Trials Review, H1, 2016 $2500

Rhabdomyosarcoma Global Clinical Trials Review, H1, 2016 Summary GlobalData’s clinical trial report, “Rhabdomyosarcoma Global Clinical Trials Review, H1, 2016″ provides an overview of Rhabdomyosarcoma clinical trials scenario. This report provides ...Read the full article

31st May, 2016 • GlobalData

 

Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2016 $2500

Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2016 Summary GlobalData’s clinical trial report, “Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2016″ provides an overview of Diabetic Ketoacidosis clinical trials scenario. ...Read the full article

31st May, 2016 • GlobalData

 

Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2016 $2500

Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2016 Summary GlobalData’s clinical trial report, “Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2016″ provides ...Read the full article

31st May, 2016 • GlobalData

 

Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016 $2500

Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData’s clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016″ provides an overview of Non-Hodgkin Lymphoma clinical trials scenario. ...Read the full article

31st May, 2016 • GlobalData

 

Diabetic Nephropathy Global Clinical Trials Review, H1, 2016 $2500

Diabetic Nephropathy Global Clinical Trials Review, H1, 2016 Summary GlobalData’s clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H1, 2016″ provides an overview of Diabetic Nephropathy clinical trials scenario. ...Read the full article

31st May, 2016 • GlobalData

 

Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016 $2500

Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016 Summary GlobalData’s clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016″ provides an overview of Bile ...Read the full article

31st May, 2016 • GlobalData

 

Follicular Lymphoma Global Clinical Trials Review, H1, 2016 $2500

Follicular Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData’s clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H1, 2016″ provides an overview of Follicular Lymphoma clinical trials scenario. ...Read the full article

31st May, 2016 • GlobalData

 
« Older Entries

Let’s get started...

Broker Rating Markets Available Fees Open an Account
Kawase Logo
1 Star2 Stars3 Stars4 Stars5 Stars
Rating 3.60 /5
(15 votes cast)
Loading...
 Shares, Indices, Forex and Oil Spread From 0.1 and 0.2% Commission Visit Website
Plus500 Logo
1 Star2 Stars3 Stars4 Stars5 Stars
Rating 4.48 /5
(452 votes cast)
Loading...
 Stocks, Commodities, Indices and Forex. Zero commissions. No monthly fees. $10 USD fee for unused account for a period of three months. Visit Website
MaxFx Logo
1 Star2 Stars3 Stars4 Stars5 Stars
Rating 4.70 /5
(89 votes cast)
Loading...
 Indices, Forex, Metals, Shares From 0.1 Raw Interbank Spread Visit Website

Due Diligence Reports

Report Title Price
UCL Business PLC – Medical Equipment – Deals and Alliances Profile
Provider: GlobalData
$250
Stereotaxis Inc (STXS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile
Provider: GlobalData
$250
F. Hoffmann-La Roche Ltd (ROG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile
Provider: GlobalData
$250
Smith & Nephew Plc (SN.) – Medical Equipment – Deals and Alliances Profile
Provider: GlobalData
$250
Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.